Physician profile
Derek J Notch
NPI 1255863072
$1,538.95
in general payments reported to CMS, 2019-2025
10 companies · $334 in 2025
The $334 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.18 · 2020: $40.13 · 2022: $25.88 · 2023: $847 · 2024: $229 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $741 · Travel and Lodging: $669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $741.07 |
| Travel and Lodging | $668.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $782.15 | 2023 | Intellis Adaptivestim |
| Abbvie INC. | $317.38 | 2023-2025 | |
| Ucb, INC. | $154.56 | 2024-2025 | Fintepla |
| Pfizer INC. | $85.28 | 2019-2025 | |
| Boston Scientific Corporation | $69.25 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Eisai INC. | $40.13 | 2020 | |
| Lundbeck LLC | $39.11 | 2025 | Vyepti |
| Ani Pharmaceuticals, INC. | $22.86 | 2025 | Purified Cortrophin Gel |
| Sk Life Science, INC. | $14.64 | 2024 | |
| Tg Therapeutics, INC. | $13.59 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Notch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.